Decoding Oncology Clinical Trials with Shikha Gaur

Decoding Oncology Clinical Trials: Finding Your Client's Real Competitors (Book 2 of the Pharma Consulting Series)

A client asks: "We're developing a PD-1 inhibitor. Who are our competitors?" Most people filter by drug class and send a long list. This book teaches you the consultant's way: match competitors on the patient, not just the drug.

What's inside (9 chapters, 33 pages):

🔹 The 9-filter framework: stage, setting, line of therapy, prior treatment, biomarker, mechanism, regimen, comparator and status

🔹 Anatomy of a ClinicalTrials.gov record: which sections matter and where the real detail hides

🔹 Endometrial cancer for consultants: dMMR vs pMMR, early vs advanced, and how first-line immunotherapy changed the market

🔹 Real trials decoded line by line: GARNET (dostarlimab), KEYNOTE-775 (pembrolizumab + lenvatinib) and KEYNOTE-189 (NSCLC)

🔹 A full client case: competitor tiers, upstream threats, and "will we gain traction?"

🔹 Toolkit: 7-step workflow, trial extraction template, 10 common mistakes, glossary

💡 Consultant Tips in every chapter.

👥 Who it's for: pharma consulting, analytics, competitive intelligence and market access professionals who know the basics and want to go further. Best read after Book 1, Learn Oncology.

📥 Format: PDF, available to download right after payment.

🔥 Launch offer: 20% off for the first 5 buyers with code TrialsOnco

Note: For educational and career-learning